- Home
- HURC vs IGMS Comparison
HURC vs IGMS Comparison
Compare HURC & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURC
- IGMS
- Stock Information
- Founded
- HURC 1968
- IGMS 1993
- Country
- HURC United States
- IGMS United States
- Employees
- HURC N/A
- IGMS N/A
- Industry
- HURC Industrial Machinery/Components
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- HURC Industrials
- IGMS Health Care
- Exchange
- HURC Nasdaq
- IGMS Nasdaq
- Market Cap
- HURC 102.5M
- IGMS 82.1M
- IPO Year
- HURC N/A
- IGMS 2019
- Fundamental
- Price
- HURC $14.96
- IGMS $1.13
- Analyst Decision
- HURC
- IGMS Hold
- Analyst Count
- HURC 0
- IGMS 8
- Target Price
- HURC N/A
- IGMS $6.14
- AVG Volume (30 Days)
- HURC 36.5K
- IGMS 152.8K
- Earning Date
- HURC 06-06-2025
- IGMS 05-20-2025
- Dividend Yield
- HURC N/A
- IGMS N/A
- EPS Growth
- HURC N/A
- IGMS N/A
- EPS
- HURC N/A
- IGMS N/A
- Revenue
- HURC $187,939,000.00
- IGMS $2,679,000.00
- Revenue This Year
- HURC N/A
- IGMS $121.76
- Revenue Next Year
- HURC N/A
- IGMS $46.83
- P/E Ratio
- HURC N/A
- IGMS N/A
- Revenue Growth
- HURC N/A
- IGMS 25.77
- 52 Week Low
- HURC $13.22
- IGMS $0.92
- 52 Week High
- HURC $23.76
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- HURC 46.96
- IGMS 39.53
- Support Level
- HURC $14.07
- IGMS $1.11
- Resistance Level
- HURC $15.39
- IGMS $1.22
- Average True Range (ATR)
- HURC 1.26
- IGMS 0.11
- MACD
- HURC 0.04
- IGMS -0.02
- Stochastic Oscillator
- HURC 24.93
- IGMS 5.56
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metal working industry through sales, service and distribution network. The company concentrated on designing user-friendly computer control systems that can be operated by both skilled and unskilled machine tool operators. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.